World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 33038864

Number of visits today: 3330

Number of downloads: 16231146

MEMBERSHIP

BPG JOURNALS

Cited by in F6Publishing

For:	Zaqout A, Almaslamani MA, Chemaitelly H, Hashim SA, Ittaman A, Alimam A, Rustom F, Daghfal J, Abukhattab M, Almukdad S, Kaleeckal AH, Latif AN, Butt AA, Bertollini R, Al-khal A, Omrani AS, Abu-raddad LJ. Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild to moderate SARS-CoV-2 in Qatar.. [DOI: 10.1101/2022.04.21.22274060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

For:

Zaqout A, Almaslamani MA, Chemaitelly H, Hashim SA, Ittaman A, Alimam A, Rustom F, Daghfal J, Abukhattab M, Almukdad S, Kaleeckal AH, Latif AN, Butt AA, Bertollini R, Al-khal A, Omrani AS, Abu-raddad LJ. Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild to moderate SARS-CoV-2 in Qatar.. [DOI: 10.1101/2022.04.21.22274060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]

Number	Citing Articles
1	Cheng MM, Reyes C, Satram S, Birch H, Gibbons DC, Drysdale M, Bell CF, Suyundikov A, Ding X, Maher MC, Yeh W, Telenti A, Corey L. Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA. Infect Dis Ther 2023;:1-15. [PMID: 36629998 DOI: 10.1007/s40121-022-00755-0] [Reference Citation Analysis]
2	Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Davis CB, Kwan BM, Mayer DA, Ong TC, Russell S, Steele J, Wogu AF, Wynia MK, Zane RD, Ginde AA. Real-World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients. J Infect Dis 2022;226:2129-36. [PMID: 35576581 DOI: 10.1093/infdis/jiac206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3	Cheng MM, Reyes C, Satram S, Birch H, Gibbons DC, Drysdale M, Bell CF, Suyundikov A, Ding X, Maher MC, Yeh W, Telenti A, Corey L. Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United States.. [DOI: 10.1101/2022.09.07.22279497] [Reference Citation Analysis]
4	Aggarwal NR, Beaty LE, Bennett TD, Carlson NE, Ginde AA. Change in Effectiveness of Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 Outpatients During the Omicron Phase.. [DOI: 10.1101/2022.06.17.22276575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]